Browse All

Current Filters

CLEAR FILTER x

TITLE

Evolution of the Treatment Landscape for Patients Diagnosed with Amyotrophic Lateral Sclerosis in the United States

Author:Ciepielewska, Malgorzata   Chandak, Aastha   Khachatryan, Artak   lavu, Alekhya   DaSilva, Polina   

Session Name:P9: General Neurology: Motor Neuron Disease 2  

Topic:General Neurology  

Program Number:P9.006  

Author Institution:Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Certara, Randor, PA  

Extension Study MT-1186-A04 Evaluating Oral Edaravone (Radicava ORS®) Continued Efficacy and Safety up to an Additional 48 Weeks in Patients With ALS

Author:Genge, Angela   Rothstein, Jeffrey   De Silva, Shari   Zinman, Lorne   Chum, Marvin   Chio, Adriano   Sobue, Gen   Doyu, Manabu   Selness, Daniel   Todorovic, Vesna   Sasson, Nissim   Takahashi, Fumihiro   Cecic, Michelle   Wamil, Art   Apple, Stephen   

Session Name:P9: General Neurology: Motor Neuron Disease 2  

Topic:General Neurology  

Program Number:P9.007  

Author Institution:Montreal Neurological Institute and Hospital, Montreal, QC, Canada  Department of Neurology, School of Medicine, Johns Hopkins University, Baltimore, MD  Woodland Research Northwest, Rogers, AR  Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada  McMaster University Health Sciences Centre, Hamilton, ON, Canada  Università degli Studi di Torino, Centro Regionale Esperto per la Sclerosi Laterale Amiotrofica (CRESLA), Torino, Italy  Nagoya University Graduate School of Medicine, Aichi Medical University, Nagoya, Japan  Department of Neurology, Aichi Medical University, Nagakute, Japan  Mitsubishi Tanabe Pharma America, Inc., Jersey City, NJ  Mitsubishi Tanabe Pharma Europe, Ltd., London, United Kingdom  NStat Solutions, Biostatistical Services, Rehovot, Israel